Skip to main content
Clinical Trials/PACTR202211721074384
PACTR202211721074384
Not yet recruiting
Phase 1

Anterior Lumbar Interbody Fusion versus Posterior Transforaminal Lumbar Interbody Fusion for treatment of Lumbar Degenerative Diseases.

Assiut university0 sites100 target enrollmentOctober 25, 2022
ConditionsSurgery

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Surgery
Sponsor
Assiut university
Enrollment
100
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 25, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • All cases operated upon for degenerative lumbar spinal disorders by anterior lumbar fusion either ALIF or ATP during 2015 to 2023, in addition to, a group of TLIF cases matched the same criteria ( diagnosis, level, number of levels, age group,…) treated within the same period. All approaches are used for management of degenerative spinal diseases according to the surgical experience and preference

Exclusion Criteria

  • \- Previous abdominal surgery with severe adhesion.
  • \- Non degenerative spinal pathology or severe osteoporosis or severe peripheral vascular disease
  • \- Patient with incomplete files or in complete follow up

Outcomes

Primary Outcomes

Not specified

Similar Trials